systhiperСистемные гипертензииSystemic Hypertension2075-082X2542-2189LLC «ИнтерМедсервис»systhiper-385Research ArticleКАРДИОЛОГИЯCARDIOLOGYДиспергируемая лекарственная форма Престариума А в лечении артериальной гипертензииDispersible Prestarium A tablets in the treatment of patients with arterial hypertensionМальчиковаС. В.MalchikovaS. V.noemail@neicon.ruТарловскаяЕ. И.TarlovskayaYe. I.noemail@neicon.ruГБОУ ВПО Кировская государственная медицинская академия Минздрава РоссииRussian FederationГБОУ ВПО Нижегородская государственная медицинская академия Минздрава РоссииRussian Federation2014231220221145254Copyright © Мальчикова С.В., Тарловская Е.И., 20222022Мальчикова С.В., Тарловская Е.И.Malchikova S.V., Tarlovskaya Y.I.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.syst-hypertension.ru/jour/article/view/385

В работе представлены данные об эффективности диспергируемой лекарственной формы периндоприла в условиях реальной клинической практики и приверженности больных терапии периндоприлом.

The research represents data on dispersing dosage form of Coversyl adherence and efficacy in real clinical practice.

диспергируемая формапериндоприлартериальная гипертензияdispersing dosage formcoversylarterial hypertensionReferencesReappraisal of European guidelines on hypertension management: a European society of hypertension task force document. J Hypertens 2009; 27: 2121-58.Reappraisal of European guidelines on hypertension management: a European society of hypertension task force document. J Hypertens 2009; 27: 2121-58.Mancia G et al. ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013; 31 (7): 1281-357.Mancia G et al. ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013; 31 (7): 1281-357.European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21 (6): 1011-53.European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21 (6): 1011-53.Mansia G et al. ESH-ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Blood Press 2007; 16 (3): 135-232.Mansia G et al. ESH-ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Blood Press 2007; 16 (3): 135-232.Britton K.A, Gaziano J.M, Djousse L. Normal systolic blood pressure and risk of heart failure in US male physicians. Eur J Heart Fail 2009; 11 (12): 1129-34.Britton K.A, Gaziano J.M, Djousse L. Normal systolic blood pressure and risk of heart failure in US male physicians. Eur J Heart Fail 2009; 11 (12): 1129-34.Kalaitzidis R.G, Bakris G.L. Prehypertension: is it relevant for nephrologists? Kidney Int 2010; 77 (3): 194-200.Kalaitzidis R.G, Bakris G.L. Prehypertension: is it relevant for nephrologists? Kidney Int 2010; 77 (3): 194-200.Mancia G, Facchetti R, Bombelli M et al. Long - term risk of mortality associated with selective and combined elevation in office, home and ambulatory blood pressure. Hypertension 2006; 47: 846-53.Mancia G, Facchetti R, Bombelli M et al. Long - term risk of mortality associated with selective and combined elevation in office, home and ambulatory blood pressure. Hypertension 2006; 47: 846-53.Sega R, Facchetti R, Bombelli M al. Prognostic value of ambulatory and home blood pressure compared with office blood pressure in the general population: follow - up results from the PAMELA study. Circulation 2005; 111: 1777-83.Sega R, Facchetti R, Bombelli M al. Prognostic value of ambulatory and home blood pressure compared with office blood pressure in the general population: follow - up results from the PAMELA study. Circulation 2005; 111: 1777-83.Леонова М.В. Пероральные лекарственные формы с модифицируемым высвобождением. Справочник поликлинического врача 2014; 10: 66-70.Леонова М.В. Пероральные лекарственные формы с модифицируемым высвобождением. Справочник поликлинического врача 2014; 10: 66-70.Эффективность и безопасность лекарственной терапии при первичной и вторичной профилактике сердечно - сосудистых заболеваний. Рекомендации ВНОК, 2011. Рацион. фармакотерапия в кардиологии. 2011; 5 (Прил.).Эффективность и безопасность лекарственной терапии при первичной и вторичной профилактике сердечно - сосудистых заболеваний. Рекомендации ВНОК, 2011. Рацион. фармакотерапия в кардиологии. 2011; 5 (Прил.).Sastry S et al. Recent technological advances in oral drug delivery - a review. Pharm Sci Tech Today 2000; 3: 138-45.Sastry S et al. Recent technological advances in oral drug delivery - a review. Pharm Sci Tech Today 2000; 3: 138-45.

The authors declare that there are no conflicts of interest present.